Universal Health Services (UHS)
(Delayed Data from NYSE)
$180.82 USD
-0.66 (-0.36%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $180.82 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Universal Health Services (UHS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$199.53 | $236.00 | $162.00 | 9.95% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Universal Health Services comes to $199.53. The forecasts range from a low of $162.00 to a high of $236.00. The average price target represents an increase of 9.95% from the last closing price of $181.48.
Analyst Price Targets (15)
Broker Rating
Universal Health Services currently has an average brokerage recommendation (ABR) of 2.06 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 2.18 a month ago based on 17 recommendations.
Of the 17 recommendations deriving the current ABR, nine are Strong Buy, representing 52.94% of all recommendations. A month ago, Strong Buy represented 47.06%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/UHS.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 8 | 8 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 8 | 7 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.06 | 2.06 | 2.18 | 2.13 | 2.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/10/2024 | Not Identified | Not Identified | Hold | Hold |
7/2/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Sell | Strong Sell |
6/26/2024 | Robert W. Baird & Co. | Michael Ha | Hold | Strong Buy |
5/20/2024 | UBS | Aj Rice | Hold | Strong Buy |
5/10/2024 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
4/25/2024 | Stephens | Scott Fidel | Hold | Hold |
4/25/2024 | Not Identified | Not Identified | Hold | Hold |
3/28/2024 | Wells Fargo Securities | Stephen Baxter | Strong Buy | Strong Buy |
3/12/2024 | Not Identified | Not Identified | Hold | Hold |
3/6/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
3/4/2024 | Goldman Sachs | Jamie Perse | Strong Buy | Strong Buy |
2/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
12/26/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.06 |
ABR (Last week) | 2.06 |
# of Recs in ABR | 17 |
Average Target Price | $199.53 |
LT Growth Rate | 15.20% |
Industry | Medical - Hospital |
Industry Rank by ABR | 17 of 252 |
Current Quarter EPS Est: | 3.37 |